Quest Diagnostics Share Price (NYSE: DGX)

$181.57

▲

2.37

(1.32%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Quest Diagnostics Stock chart to analyse performance

Quest Diagnostics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$179.76
Today's High:$182.31
$181.57
1.0%
Downside
Day's Volatility :1.4%
Upside
0.41%
52 Weeks Low:$146.17
52 Weeks High:$185.62
$181.57
19.5%
Downside
52 Weeks Volatility :21.25%
Upside
2.18%

Quest Diagnostics Stock Returns

Period	Quest Diagnostics Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	4.11%	3.6%	0.0%
6 Months	2.61%	-7.7%	0.0%
1 Year	15.67%	-12.6%	0.0%
3 Years	43.97%	10.2%	-4.1%

Quest Diagnostics Inc. Key Stats

Check Quest Diagnostics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$179.2
Open	$179.76
Today's High	$182.31
Today's Low	$179.76
Market Capitalization	$20.3B
Today's Volume	$731.5K
52 Week High	$185.62
52 Week Low	$146.17
Revenue TTM	$10.5B
EBITDA	$2.1B
Earnings Per Share (EPS)	$8.36
PE Ratio	21.73
Dividend Yield	1.73%
Profit Margin	9.03%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	14.26%

Stock Returns calculator for Quest Diagnostics Stock including INR - Dollar returns

The Quest Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Quest Diagnostics investment value today

Current value as on today

₹1,20,956

Returns

₹20,956

(+20.96%)

Returns from Quest Diagnostics Stock

₹15,672 (+15.67%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Quest Diagnostics Stock

-44%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Quest Diagnostics Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Quest Diagnostics Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	902	2.35	0.03%

Global Institutional Holdings in Quest Diagnostics Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
12.73%
BlackRock Inc
9.03%
T. Rowe Price Associates, Inc.
6.43%
State Street Corp
4.63%
JPMorgan Chase & Co
3.37%
Victory Capital Management Inc.
2.80%

Analyst Recommendation on Quest Diagnostics Stock

Rating

Trend

Hold

40%Buy

59%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Quest Diagnostics(by analysts ranked 0 to 5 stars)

Quest Diagnostics Share Price Target

What analysts predicted

Upside of 3.64%

Target:

$188.19

Current:

$181.57

Quest Diagnostics share price target is $188.19, a slight Upside of 3.64% compared to current price of $181.57 as per analysts' prediction.

Quest Diagnostics Stock Insights

Price Movement
In the last 3 years, DGX stock has moved up by 44.9%
Increasing Revenue
Revenue is up for the last 7 quarters, 2.28B → 2.76B (in $), with an average increase of 3.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 220.0M → 281.0M (in $), with an average increase of 21.7% per quarter
DGX vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 18.5%
DGX vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.8% return, outperforming this stock by 40.9%
Price to Sales
ForDGX every $1 of sales, investors are willing to pay $1.9, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Quest Diagnostics Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$7.7B	↑ 2.59%
Net Income	$858.0M	↑ 16.58%
Net Profit Margin	11.11%	↑ 1.34%

	FY20	Y/Y Change
Revenue	$9.4B	↑ 22.15%
Net Income	$1.4B	↑ 66.78%
Net Profit Margin	15.16%	↑ 4.05%

	FY21	Y/Y Change
Revenue	$10.8B	↑ 14.32%
Net Income	$2.0B	↑ 39.41%
Net Profit Margin	18.49%	↑ 3.33%

	FY22	Y/Y Change
Revenue	$9.9B	↓ 8.39%
Net Income	$946.0M	↓ 52.58%
Net Profit Margin	9.57%	↓ 8.92%

	FY23	Y/Y Change
Revenue	$9.3B	↓ 6.38%
Net Income	$854.0M	↓ 9.73%
Net Profit Margin	9.23%	↓ 0.34%

	FY24	Y/Y Change
Revenue	$9.9B	↑ 6.7%
Net Income	$871.0M	↑ 1.99%
Net Profit Margin	8.82%	↓ 0.41%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.4B	↑ 3.41%
Net Income	$194.0M	↑ 1.04%
Net Profit Margin	8.2%	↓ 0.19%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 1.31%
Net Income	$229.0M	↑ 18.04%
Net Profit Margin	9.55%	↑ 1.35%

	Q3 FY24	Q/Q Change
Revenue	$2.5B	↑ 3.8%
Net Income	$226.0M	↓ 1.31%
Net Profit Margin	9.08%	↓ 0.47%

	Q4 FY24	Q/Q Change
Revenue	$2.6B	↑ 5.35%
Net Income	$222.0M	↓ 1.77%
Net Profit Margin	8.47%	↓ 0.61%

	Q1 FY25	Q/Q Change
Revenue	$2.7B	↑ 1.18%
Net Income	$220.0M	↓ 0.9%
Net Profit Margin	8.3%	↓ 0.17%

	Q2 FY25	Q/Q Change
Revenue	$2.8B	↑ 4.11%
Net Income	$281.0M	↑ 27.73%
Net Profit Margin	10.18%	↑ 1.88%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$2.7B	↑ 3.22%

	FY20	Y/Y Change
Profit	$3.6B	↑ 35.11%

	FY21	Y/Y Change
Profit	$4.2B	↑ 15.85%

	FY22	Y/Y Change
Profit	$3.4B	↓ 18.44%

	FY23	Y/Y Change
Profit	$3.1B	↓ 11.07%

	FY24	Y/Y Change
Profit	$3.2B	↑ 6.26%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$771.0M	↑ 4.19%

	Q2 FY24	Q/Q Change
Profit	$804.0M	↑ 4.28%

	Q3 FY24	Q/Q Change
Profit	$811.0M	↑ 0.87%

	Q4 FY24	Q/Q Change
Profit	$858.0M	↑ 5.8%

	Q1 FY25	Q/Q Change
Profit	$863.0M	↑ 0.58%

	Q2 FY25	Q/Q Change
Profit	$944.0M	↑ 9.39%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 3.58%
Investing Cash Flow	$-411.0M	↓ 48.69%
Financing Cash Flow	$225.0M	↓ 156.11%

	FY20	Y/Y Change
Operating Cash Flow	$2.0B	↑ 61.3%
Investing Cash Flow	$-772.0M	↑ 87.83%
Financing Cash Flow	$-1.3B	↓ 663.11%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 11.37%
Investing Cash Flow	$21.0M	↓ 102.72%
Financing Cash Flow	$-2.5B	↑ 100.47%

	FY22	Y/Y Change
Operating Cash Flow	$1.7B	↓ 23.06%
Investing Cash Flow	$-543.0M	↓ 2685.71%
Financing Cash Flow	$-1.7B	↓ 31.81%

	FY23	Y/Y Change
Operating Cash Flow	$1.3B	↓ 25.96%
Investing Cash Flow	$-1.1B	↑ 95.4%
Financing Cash Flow	$160.0M	↓ 109.24%

	FY24	Y/Y Change
Operating Cash Flow	$1.3B	↑ 4.87%
Investing Cash Flow	$-2.5B	↑ 140.15%
Financing Cash Flow	$1.1B	↑ 577.5%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$154.0M	↓ 70.78%
Investing Cash Flow	$-213.0M	↑ 86.84%
Financing Cash Flow	$-153.0M	↓ 217.69%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$360.0M	↑ 133.77%
Investing Cash Flow	$-200.0M	↓ 6.1%
Financing Cash Flow	$-363.0M	↑ 137.25%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$356.0M	↓ 1.11%
Investing Cash Flow	$-1.6B	↑ 716.5%
Financing Cash Flow	$1.8B	↓ 587.6%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$464.0M	↑ 30.34%
Investing Cash Flow	$-502.0M	↓ 69.26%
Financing Cash Flow	$-170.0M	↓ 109.6%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$314.0M	↓ 32.33%
Investing Cash Flow	$-115.0M	↓ 77.09%
Financing Cash Flow	$-561.0M	↑ 230.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$544.0M	↑ 73.25%
Investing Cash Flow	$-124.0M	↑ 7.83%
Financing Cash Flow	$-293.0M	↓ 47.77%

Quest Diagnostics Technicals Summary

Sell

Neutral

Buy

Quest Diagnostics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Quest Diagnostics Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quest Diagnostics Inc.	6.27%	2.61%	15.67%	43.97%	65.59%
Agilent Technologies Inc.	10.74%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.6%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	6.38%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.47%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	4.47%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quest Diagnostics Inc.	21.73	21.73	1.57	9.75	0.14	0.06	0.02	64.54
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quest Diagnostics Inc.	Hold	$20.3B	65.59%	21.73	9.03%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

Quest Diagnostics Dividend announcements

Quest Diagnostics Dividends December, 2025
In the quarter ending December,2025. Quest Diagnostics has declared dividend of $0.80

About Quest Diagnostics Inc.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Organization	Quest Diagnostics
Employees	55000
CEO	Mr. James E. Davis
Industry	Health Services

Key Management of Quest Diagnostics Inc.

Name	Title
Mr. James E. Davis	Chairman, CEO & President
Mr. Sam A. Samad	Executive VP & CFO
Mr. Michael E. Prevoznik J.D.	Senior VP & General Counsel
Ms. Catherine T. Doherty	Executive Vice President of Regional Businesses
Mr. Karthik Kuppusamy Ph.D.	Senior Vice President of Clinical Solutions
Mr. Michael J. Deppe	Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Murali Balakumar	Senior VP and Chief Information & Digital Officer
Mr. Shawn C. Bevec	Vice President of Investor Relations
Ms. Kristin Lee Wallace Esq.	Senior VP & Chief Compliance Officer
Mr. Garry Clark	Senior VP and Chief Marketing & Communications Officer

Important FAQs about investing in DGX Stock from India :

What is Quest Diagnostics share price today?

Quest Diagnostics share price today is $181.57 as on August 30, 2025 at 1:29 am IST at the close of the market. Quest Diagnostics share today touched a day high of $182.31 and a low of $179.76.

What is the 52 week high and 52 week low for Quest Diagnostics share?

Quest Diagnostics share touched a 52 week high of $185.62 and a 52 week low of $146.17. Quest Diagnostics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $181.57, lower by 2.18% versus the 52 week high.

How to invest in Quest Diagnostics Stock (DGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Quest Diagnostics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quest Diagnostics Shares that will get you 0.0083 shares as per Quest Diagnostics share price of $181.57 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Quest Diagnostics Stock (DGX) from India?

Indian investors can start investing in Quest Diagnostics (DGX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Quest Diagnostics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Quest Diagnostics share’s latest price of $181.57 as on August 30, 2025 at 1:29 am IST, you will get 0.0551 shares of Quest Diagnostics. Learn more about fractional shares .

What are the returns that Quest Diagnostics has given to Indian investors in the last 5 years?

Quest Diagnostics stock has given 65.59% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?